Phospholipase C (PLC) enzymes hydrolyze membrane phosphatidylinositol 4,5 bisphosphate (PIP 2 ) and regulate Ca 2؉ and protein kinase signaling in virtually all mammalian cell types. Chronic activation of the PLC⑀ isoform downstream of G protein-coupled receptors (GPCRs) contributes to the development of cardiac hypertrophy. We have previously shown that PLC⑀-catalyzed hydrolysis of Golgi-associated phosphatidylinositol 4-phosphate (PI4P) in cardiac myocytes depends on G protein ␤␥ subunits released upon stimulation with endothelin-1. PLC⑀ binds and is directly activated by Ras family small GTPases, but whether they directly interact with G␤␥ has not been demonstrated. To identify PLC⑀ domains that interact with G␤␥, here we designed various single substitutions and truncations of WT PLC⑀ and tested them for activation by G␤␥ in transfected COS-7 cells. Deletion of only a single domain in PLC⑀ was not sufficient to completely block its activation by G␤␥, but blocked activation by Ras. Simultaneous deletion of the C-terminal RA2 domain and the N-terminal CDC25 and cysteine-rich domains completely abrogated PLC⑀ activation by G␤␥, but activation by the GTPase Rho was retained. In vitro reconstitution experiments further revealed that purified G␤␥ directly interacts with a purified fragment of PLC⑀ (PLC⑀-PH-RA2) and increases PIP 2 hydrolysis. Deletion of the RA2 domain decreased G␤␥ binding and eliminated G␤␥ stimulation of PIP 2 hydrolysis. These results provide first evidence that G␤␥ directly interacts with PLC⑀ and yield insights into the mechanism by which ␤␥ subunits activate PLC⑀.
G protein-coupled receptors (GPCRs) 2 regulate a wide variety of cellular functions through stimulation of a few canonical signal transduction cascades. One major GPCR-stimulated pathway is the agonist-dependent hydrolysis of phosphatidylinositol 4,5 bisphosphate (PIP 2 ) by phospholipase C (PLC) to regulate intracellular Ca 2ϩ and protein kinase activation (1) . PLC signaling is stimulated by both receptor tyrosine kinases (RTKs) and GPCRs and regulates multiple cellular functions in normal and disease states. Thirteen PLC isoforms have been identified with some common structural features (2) (3) (4) (5) . All PLC isoforms contain a pleckstrin homology (PH) domain, an EF-hand domain, a highly conserved catalytic core domain (composed of the X and Y domains separated by a linker region) and a phospholipid-binding C2 domain. The diversity in regulation of the PLCs arises in large part from regions outside the conserved core domains.
The PLC␤ family of PLCs is directly activated by G␣ q or G␤␥ subunits with varying efficacies and potencies (6 -11) . PLC⑀ is a more recently discovered PLC isoform and is also downstream of GPCRs, as well as RTKs (12) (13) (14) (15) . PLC⑀ binds directly to members of the Ras family of small GTPases including Ras, Rap, and Rho. Ras family members can be activated by both GPCRs and RTKs and subsequently activate PLC⑀ (5) . G protein ␤␥ subunits have also been shown to regulate PLC⑀ in a COS-7 cell co-transfection system, but direct activation by G␤␥ has not been demonstrated (16) .
PLC⑀ has a unique domain architecture where, apart from conserved core domains, it has N-terminal cysteine-rich (Cys) and CDC25 guanine nucleotide exchange factor (GEF) domains that activate Rap, and two C-terminal Ras-association domains (RA1 and RA2) ( Fig. 1A) . A putative PH domain was identified in silico, but its properties have not been studied biochemically (16) . The RA2 domain binds directly to Ras and is required for activation by Ras (12) . A domain required for activation by Rho is in the Y catalytic domain but a direct binding site for Rho has not been identified (17) . Although G␤␥ has been shown to activate PLC⑀, the domains on PLC⑀ required for this activation have not been delineated (17) .
We recently found that G␤␥-dependent regulation of PLC⑀ at the Golgi apparatus in cardiac myocytes regulates local PI4P hydrolysis, protein kinase D (PKD) activation, gene expression, and hypertrophy (18) . Thus understanding how PLC⑀ is regulated by G␤␥ is important to fully understand this process. Here we identified two independent domains of PLC⑀ that are involved in its regulation by G␤␥ and demonstrate direct interactions between G␤␥ and PLC⑀. These data place PLC⑀ activation directly downstream of GPCRs.
Results

Regulation of PLC⑀ by G␤␥ subunits
G protein-dependent activation of PLC⑀ is difficult to reconstitute with purified G proteins (12, 17) , so to understand the mechanism by which G␤␥ regulates PLC⑀, we confirmed previous work showing that G␤␥ co-transfected with PLC⑀ increases accumulation of inositol phosphates (IP) in COS-7 cells labeled with [ 3 H]inositol (16) . When G␤ and ␥ subunits are transfected in the absence of transfected PLC, increased IP accumulation is observed because of stimulation of endogenous PLCs present in COS-7 cells (Fig. 1 , B and C) (19) . However, cells co-transfected with G␤␥ and PLC⑀ markedly increased IP accumulation in a concentration-dependent manner (Fig. 1, B and C). To confirm that free G␤␥ is necessary for activation of PLC⑀ in COS-7 cells, we included G␣ i1 in the cotransfection to bind and sequester free G␤␥. In the presence of G␣ i1 , G␤␥-dependent accumulation of IP was inhibited (Fig.  1C) . These results indicate that activation of PLC⑀ by G␤␥ requires free G␤␥ and confirms previously reported G␤␥-dependent activation of PLC⑀ (16) .
Effect of C-terminal domain mutation and deletion on activation of PLC⑀ by G␤␥
G␤␥ has been reported to activate Ras (20) . Mutation of the lysine residues 2150 and 2152 in the PLC⑀ RA2 domain to glutamate ( Fig. 2A ) inhibits activation of PLC⑀ by Ras (12) . Western blot analysis of the mutants showed similar expression of PLC⑀ WT and Lys-Glu ( Fig. 2B ). To investigate whether activation of PLC⑀ by G␤␥ in COS-7 cells is mediated indirectly through endogenous activated Ras, we tested PLC⑀ 2150/2152 Lys-Glu for activation by G␤␥ and Rho to rule out indirect activation by endogenous Ras. Co-transfection of PLC⑀ Lys-Glu with G␤␥ or constitutively active Rho (RhoG14V) in COS-7 cells resulted in marked accumulation of IP (Fig. 2C, left and middle panels) in contrast to constitutively activated Ras (RasG12V) co-transfected cells (Fig. 2C, right panel) . These results confirm previously published data indicating that activation of PLC⑀ by G␤␥ or Rho is independent of endogenous Ras activation in COS-7 cells (16) .
To determine whether the RA2 domain of PLC⑀ is required for its activation by G␤␥, we next deleted residues 2114 -2281 composing the RA2 domain and tested for activation by G␤␥, Rho, and Ras ( Fig. 2A ). The unstimulated basal activity of PLC⑀-⌬RA2 when co-transfected with empty vector was significantly lower than PLC⑀ WT despite similar levels of expression ( Fig. 2 , B and D). RasG12V was unable to activate this mutant as expected ( Fig. 2D , right panel). Co-transfection of this mutant with RhoG14V caused significant accumulation of IP but not to the levels of PLC⑀ WT indicating the enzyme is still active and can be activated ( Fig. 2D , middle panel). G␤␥ transfection resulted in a small but statistically significant increase in IP accumulation when PLC⑀-⌬RA2 was co-transfected compared to control with G␤␥ only transfected ( Fig. 2D, left panel) . The reduced levels of IP accumulation may be because of the lower basal activity of PLC⑀-⌬RA2. However, because the Rho activation is relatively robust it suggests that the RA2 domain is important for G␤␥ stimulation. This will be explored in more detail later.
Effect of N-terminal domain deletions on PLC⑀ activation by G␤␥
To investigate the involvement of the N-terminal domains of PLC⑀ in G␤␥-mediated activation, a series of N-terminal truncations of PLC⑀ were created (Fig. 3A ). It has been reported that the N-terminal domains are not essential for PLC⑀ activation by G␤␥ or Rho (17). The basal activity of PLC⑀-CDC25-RA2 was significantly higher than PLC⑀ WT when co-transfected with empty vector (Fig. 3C ), whereas PLC⑀-PH-RA2 and EF-RA2 had decreased basal activity compared with PLC⑀ WT (Fig. 3 , D and E). There was no correlation between expression levels of the mutant PLC⑀ proteins ( Fig. 3B ) and observed basal activities ( Fig. 3 , C-E). PLC⑀-PH-RA2 and EF-RA2 had significantly reduced capacity for activation by free G␤␥, whereas activation by RhoG14V was largely retained ( Fig. 3 , C-E). The reduced accumulation of IP in the presence of the mutants (PH-RA1 and EF-RA2) and G␤␥ or RhoG14V may be because of their lower basal activity, however, G␤␥ stimulation of the EF-RA2 PLC⑀ was still minimal. Overall, our results indicate that deletion of the N-terminal domains is not sufficient to completely inhibit activation of PLC⑀ by G␤␥ but significantly reduces it.
Effect of simultaneous N-terminal and C-terminal domain deletions on PLC⑀ activation by G␤␥
The results of the foregoing experiments could indicate that some PLC⑀ activation by G␤␥ requires interaction with only the catalytic core. An alternate hypothesis is that PLC⑀ activation by G␤␥ may involve multiple interaction sites at the C terminus and the N terminus. To test these hypotheses, we made a series of combined truncations of PLC⑀ that lack both the N-and C-terminal domains as shown in Fig. 4A . COS-7 cells were transfected with either G␤␥ or RhoG14V and one of the mutant PLC⑀ constructs shown in Fig. 4A . A Western blot showing expression levels of these constructs is seen in Fig. 4B . Although the basal activity of CDC25-RA1 is significantly lower than PLC⑀ WT as shown in Fig. 4C , co-transfection with G␤␥ resulted in a small but statistically significant accumulation of IP relative to control without PLC⑀ co-expression. RhoG14V was also able to activate this mutant. Deletion of the CDC25 domain completely eliminated G␤␥-dependent accumulation of IP above levels of cells transfected with G␤␥ alone (Fig. 4D , left panel). In contrast, co-transfection of this PLC⑀ mutant with RhoG14V resulted in some Rho-stimulated accumulation of IP, confirming that this construct can be activated to some level ( Fig. 4D, right panel) . EF-RA1 is also not activated upon 
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co-transfection with G␤␥. In this case co-transfection with RhoG14V also did not result in accumulation of IP above levels of cells transfected with G␤␥ or Rho alone (Fig. 4E ). These data together suggest that PLC⑀ activation by G␤␥ requires both the N (cysteine-rich and CDC25 domains) and C termini (RA2 domain) for full activation of PLC⑀.
Constitutive membrane localization of PLC⑀-EF-RA1 rescues Rho-dependent activation, but not G␤␥-dependent activation
Confounding interpretation of these experiments is the reduction in basal activity associated with many of the domain deletion mutations. In particular, the EF-RA1 construct shows little basal activity and no activation by either Rho or G␤␥. We hypothesized that this could be because of a loss in membrane association of the enzyme. To test this, we designed a EF-RA1 variant with a C-terminal CAAX box to allow for C-terminal prenylation and constitutive membrane localization as shown in previous studies (21) (Fig. 5A) . Western blot analysis of the mutants showed similar levels of expression of EF-RA1 and EF-RA1 CAAX, which were slightly increased relative to PLC⑀ WT expression ( Fig. 5B) . In contrast to EF-RA1 transfected cells, EF-RA1 CAAX transfected cells showed elevated basal activity above empty vector transfected cells, indicating that this construct was indeed active when localized to the plasma membrane ( Fig. 5C ). Interestingly, the EF-RA1 CAAX mutant rescued activation by Rho but not G␤␥ (Fig. 5C ). The data indicate that a PLC⑀ mutant lacking the cysteine-rich, CDC25, and RA2 domains can be activated by Rho when targeted to the membrane, but cannot be stimulated by G␤␥. These data strongly support these domains as being required for G␤␥ activation.
PLC⑀ directly interacts with G␤␥ and increases PIP 2 hydrolysis
To test whether G␤␥ directly interacts with PLC⑀, PLC⑀ truncations lacking the cysteine-rich and CDC25 domains (PH-RA2), or the cysteine-rich, CDC25, and RA2 domains (PH-RA1) were expressed and purified (Figs. 6A and 7A). To test for direct binding of G␤␥ to PLC⑀, purified biotinylated G␤␥ (bG␤␥) was mixed with purified PLC⑀-PH-RA2 and precipitated with neutravidin beads. PLC⑀-PH-RA2 was readily detected associated with beads bound to bG␤␥, but not beads alone (Fig. 6B) . The two bands observed are likely the result of proteolysis that occurs during the incubation. To test the specificity of G␤␥ interaction with PLC⑀, purified PLC⑀-PH-RA2 and bG␤␥ were incubated with or without G␣ i1 -GDP to sequester free G␤␥. G␣ i1 -GDP strongly inhibited the pulldown of PLC⑀-PH-RA2 by bG␤␥ (Fig. 6, B and  C) , demonstrating a direct and specific interaction between PLC⑀ and G␤␥.
Unlike the PLC␤ isoforms, reconstitution of PLC⑀ activation with purified components has been difficult to demonstrate, and generally the amount of PLC⑀ activation observed upon incubation with purified upstream activators such as Rho and Ras is minimal (17, 22) . Nevertheless, to test the specificity of G␤␥ activation of PLC⑀, purified PLC⑀-PH-RA2 and G␤␥ were incubated with or without G␣ i1 -GDP in reconstituted 
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lipid vesicles containing inositol PIP 2 , and the amount of [ 3 H]IP 3 produced was measured. Fig. 6D shows a small but statistically significant increase in PIP 2 hydrolysis by PLC⑀-PH-RA2 when G␤␥ is added. This activation was inhibited by G␣ i1 -GDP confirming that this increase is through direct interactions of PLC⑀ with G␤␥. This is also the first direct demonstration of G␤␥-dependent activation of PLC⑀ using reconstituted proteins.
Our data from the COS-7 cell co-transfection experiments indicate that PLC⑀ activation by G␤␥ requires both the N ter- Biotinylated G␤ 1 ␥ 2 was used to pull down PLC⑀ mutants in the presence of neutravidin beads. Representative blot showing direct pulldown of PLC⑀-PH-RA2 with G␤ 1 ␥ 2 and inhibition of this interaction by G␣ i1 -GDP. 50 ng of purified PLC⑀-PH-RA2 was mixed with purified 15 nM biotinylated G␤ 1 ␥ 2 in the presence or absence of G␣ i1 -GDP for 2 h. 15 l 50% magnetic neutravidin bead slurry was added and the mix was incubated for another 2 h. Pellet was washed thrice and subjected to gel electrophoresis and Western blotting. Input is 1/20 of supernatant. C, quantitation of the PLC⑀ band densities from three experiments as in B (PH-RA2 binding was normalized to 100%). The data shown are mean Ϯ S.E. and analyzed by Student's t test. ***, p Ͻ 0.001 versus PH-RA2 binding in the absence of G␣ i1 -GDP. D, 300 nM G␤ 1 ␥ 2 alone or with 600 nM G␣ i1 -GDP was incubated with 10 ng PLC⑀ PH-RA2. The effect on PLC⑀ mutant activity is shown. Values are the mean Ϯ S.E. of triplicate determinations and representative of three independent experiments and analyzed by one-way ANOVA with Dunnett's post test.
minus (cysteine-rich and CDC25 domains) and C terminus (RA2 domain) that are potentially compensatory in the absence of one or the other. Therefore, we hypothesized that if PLC⑀ is directly regulated by G␤␥ binding to the RA2 domain, G␤␥ will bind to PLC⑀-PH-RA2 but not PH-RA1. To test this, purified bG␤␥ and N-and C-terminally truncated PLC⑀ mutants (PH-RA2 or PH-RA1) were incubated and then precipitated with neutravidin beads. As shown in Fig. 7, B and C, PLC⑀-PH-RA2 was strongly pulled down with bG␤␥ bound to beads. In contrast PLC⑀-PH-RA1 was only weakly pulled down with bG␤␥.
We next tested the ability of purified G␤␥ to activate purified PLC⑀-PH-RA2 or PH-RA1 in reconstituted lipid vesicles containing [ 3 H]PIP 2 . PH-RA1 had significantly less basal activity than PH-RA2 (Fig. 7D) . G␤␥ also activated PLC⑀-PH-RA2, but not PH-RA1, in a concentration-dependent manner (Fig. 7D ) consistent with the decreased binding of G␤␥ to PH-RA1 ( Fig.  7B ) and the lack of activation of this construct in COS-7 cells (Fig. 4D) . Overall, these results suggest that the activation of PLC⑀ involves a direct interaction with G␤␥ that requires the C terminus RA2 domain and the N-terminal cysteine-rich and CDC25 domains.
Discussion
In our previous work we showed that inhibiting G␤␥ with the C terminus of G protein-coupled receptor kinase 2 (GRK2ct), or with gallein, inhibited PLC⑀-dependent PI4P hydrolysis in cardiac myocytes (18) . Activation of PLC⑀ can be mediated by small GTPases and/or G␤␥ (12, 13, 16, 17) . To date, direct regulation of PLC⑀ by G␤␥ has not been reported. If indeed free G␤␥ subunits activate PLC⑀, G␣ i1 -GDP should form an inactive heterotrimer with G␤␥, preventing PLC⑀ activation. We confirmed that co-transfection of cells with cDNAs encoding G␤␥, PLC⑀, and G␣ i1 completely prevented activation of PLC⑀ mediated by free G␤␥. Our results also demonstrate that G␤␥ directly interacts with PLC⑀ to increase PIP 2 hydrolysis. In addition, the results from domain deletion analysis of PLC⑀ show an unexpected involvement of the RA2 and CDC25 domains in the activation of PLC⑀ by G␤␥. 
Regulation of PLC⑀ by G␤␥
Regulation of PLC⑀ by Ras is through direct binding to the RA2 domain (12) . The regulation of PLC⑀ by G␤␥ is not understood. It was previously reported that PLC⑀ lacking the N-terminal domains retained activation by G␤␥ subunits, Ras, and Rho, suggesting activation was not dependent upon the PLC⑀ N-terminal domains (17). In addition, it was also reported that PLC⑀-CDC25-C2 can be stimulated by G␤␥ subunits, but not by Ras, suggesting that G␤␥ activation was independent of the RA2 domain (17). Our results generally support these findings.
The most compelling data indicating that G␤␥ may be interacting with both the CDC25 domain and the RA2 domain is that simultaneous deletion of the N-terminal cysteine-rich and CDC25 domains and the RA2 C-terminal domain resulted in complete loss of activation by free G␤␥, but not Rho (Fig. 4D ). Further evidence that the CDC25 and RA2 domains interact with G␤␥ is that simultaneous deletion of the N-terminal cysteine-rich, CDC25, and PH domains and the RA2 C-terminal domain led to loss of PLC⑀ activation. Addition of a CAAX sequence to target this mutant to the membrane rescued Rho activation but not G␤␥ activation ( Figs. 4 and 5) . Because deletion of the cysteine-rich domain alone has no effect on G␤␥ regulation, these data support a role for both the N-terminal CDC25 domain and the C-terminal RA2 domain in G␤␥-dependent activation of PLC⑀.
The inability of G␤␥ to activate the PLC⑀-PH-RA1 mutant in COS-7 cells implies that this mutant lacks a binding site for G␤␥. The purified PLC⑀-PH-RA1 protein had enzymatic activity but was not activated by G␤␥ and only weakly bound to G␤␥ in pulldown assays for protein binding supporting the COS-7 cell data. Purified PLC⑀-PH-RA2, which retains one of the two G␤␥-binding sites (RA2) implicated in the transfection experiments, bound G␤␥ more strongly than PLC⑀-PH-RA1, and was activated by G␤␥, implicating the RA2 domain as a binding site for G␤␥. These results demonstrate for the first time that PLC⑀ is directly stimulated by G protein ␤␥ subunits and a requirement for the RA2 domain. The activation of PLC⑀-PH-RA2 by G␤␥ in vitro may be weak because it is missing the important CDC25 domain-binding site, or because as has been raised previously, PLC⑀ activation is notoriously difficult to activate in vitro. We have been unable to purify full-length PLC⑀ to discriminate between these possibilities.
In summary we have demonstrated that PLC⑀ is directly regulated by G␤␥ through binding to the RA2 domain with additional contributions from the CDC25 domain. Potential mechanisms for regulation of PLC⑀ by G␤␥ are shown in Fig. 8 . In the first scenario, free G␤␥ interacts with and activates PLC⑀ by binding to the N-terminal CDC25 domain and to the C-terminal RA2 domain through two independent sites, and interaction with both is required for full activation. An alternative model is that, in the three-dimensional structure of PLC⑀, the RA2 and CDC25 domains are in close proximity and form a single G␤␥-binding site.
Our previous observation using a neonatal rat ventricular myocyte (NRVM) model of cardiac hypertrophy showed that PLC⑀-mediated PI4P hydrolysis at the Golgi is G␤␥-dependent (18) . Furthermore, PLC⑀ is also implicated in the development of cardiac hypertrophy and has been shown to localize to a subcellular compartment in neonatal rat ventricular myocytes (23) . Our studies indicate that G␤␥ activation of PLC⑀ is direct and likely occurs at the Golgi apparatus in cardiac myocytes. These studies extend our knowledge of the regulation of PLC⑀ by G␤␥ and could result in novel strategies for targeting PLC⑀ regulation in hypertrophy, heart failure, and other diseases linked to PLC⑀ activation. 
Experimental procedures
Materials and plasmids
Full-length WT rat PLC⑀ pCMV-scriptPLC⑀-FLAG (a kind gift of Dr. Grant Kelley) was used in most experiments. AVI-G␤ 1 , G␥ 2 , and enhanced YFP (EYFP) were in pCI-neo vector. HA-tagged HRasG12V was in pDCR. RhoG14V was in 3ϫ HA pcDNA3.1ϩ vector. G␣ i1 was in pcDNA3.1ϩ. Rabbit anti-PLC⑀ (2163) was used as described previously (24) .
Construction of PLC⑀ domain deletions and mutations
Variations of the WT rat PLC⑀ pCMV-scriptPLC⑀-FLAG were generated using QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent) and manufacturer's protocol followed. The following constructs were verified by sequencing: pCMV-scriptPLC⑀ Lys-Glu-FLAG (lysine residues 2150 and 2152 in the RA2 domain changed to glutamate), pCMV-scriptPLC⑀-CDC-RA2-FLAG (⌬2-393), pCMV-scriptPLC⑀-PH-RA2-FLAG (⌬2-836), pCMV-scriptPLC⑀-EF-RA2-FLAG (⌬2-1197), pCMV-scriptPLC⑀-CDC25-RA1-FLAG (394 -2113), pCMV-scriptPLC⑀-PH-RA1-FLAG (837-2113), pCMV-scriptPLC⑀-EF-RA1-FLAG (1198 -2113). pCMV-scriptPLC⑀-EF-RA1-CAAX (C-terminal amino acids 175-188 of KRAS4B (KKKKKKSKTKCVIM) was made using a modified Quik Change Lightning Site-Directed Mutagenesis protocol. Protein expression was confirmed by Western blotting using anti-PLC⑀ 2163 antibody.
The cDNAs PLC⑀-PH-RA2 (837-2281) and PH-RA1 (837-2098) variants used for in vitro assays were subcloned into pFastBac HTA to yield N-terminal His-tagged protein. Baculoviruses were generated using a recombinant baculovirus system (Invitrogen/Thermo Fisher Scientific) Sf9 (Spodoptera frugiperda) insect cells (Invitrogen or Expression Systems) were used for virus production and protein expression. Cells were infected with baculovirus at a multiplicity of infection of 1, harvested at 48 -72 h post infection, and flash frozen in liquid nitrogen.
Transfection of COS-7 cells and quantitation of phospholipase C activity
All cell culture reagents were obtained from Invitrogen. COS-7 cells were obtained from ATCC. COS-7 cells were seeded in 12-well culture dishes at a density of 2 ϫ 10 5 cells per well and maintained in high-glucose Dulbecco's modified Eagle's medium containing 5% fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin at 37°C. The following day, indicated vectors were transfected using Lipofectamine 2000 (Invitrogen) transfection reagent (2 l Lipofectamine per 1 g of DNA). Total DNA varied from 700 to 900 ng per well and included EYFP control vector as necessary to maintain equal amount of DNA per well within individual experiments. Approximately 24 h after transfection, the culture medium was changed to low-inositol Ham's F-10 medium (Gibco) containing 1.5 Ci/well Myo-[2-3 H(N)]inositol (Perkin Elmer) for 12-16 h. Accumulation of [ 3 H]inositol phosphate was quantitated after the addition of 10 mM LiCl for 1 h to inhibit inositol monophosphate phosphatases. Media were aspirated and cells washed with 1ϫ PBS, followed by the addition of ice-cold 50 mM formic acid to lyse cells. Soluble cell lysates containing [ 3 H]inositol phosphate were transferred onto Dowex AGX8 chromatography columns to separate total IP by anion exchange chromatography. Columns were washed with 50 mM and eluted with 100 mM formic acid into scintillation vials containing scintillation fluid and counted.
Purification of free biotinylated G␤␥
Purification of in vivo biotinylated G␤␥ (bG␤␥) was performed by co-expressing G␤␥ with His 6 G␣ i1 in High Five insect cells and nickel-agarose chromatography as described previously (25, 26) .
Purification of His 6 PLC⑀-PH-RA2 and PH-RA1
Baculovirus-infected Sf9 cells expressing PLC⑀-PH-RA2 or PH-RA1 were lysed by Dounce on ice in lysis buffer containing 20 mM HEPES, pH 8, 50 mM NaCl, 10 mM ␤-mercaptoethanol, 0.1 mM EDTA, 0.1 M EGTA, and two Roche EDTA-free protease inhibitor tablets at one-third strength. The lysate was centrifuged at 100,000 ϫ g, and the supernatant was loaded onto a Ni-NTA column pre-equilibrated with buffer A (20 mM HEPES, pH 8, 100 mM NaCl, 10 mM ␤-mercaptoethanol, 0.1 mM EDTA, and 0.1 M EGTA). The column was washed with 3 column volumes (CVs) of buffer A, followed by 3 CVs of buffer A supplemented with 300 mM NaCl and 10 mM imidazole. The protein was eluted from the column with 3-10 CVs of buffer A supplemented with 200 mM imidazole. Proteins were concentrated and loaded onto tandem Superdex 200 Increase columns (10/ 300 GL; GE Healthcare) equilibrated with SEC buffer (20 mM HEPES, pH 8, 200 mM NaCl, 2 mM DTT, 0.1 mM EDTA, and 0.1 M EGTA). Fractions of interest were confirmed by SDS-PAGE, pooled, concentrated, and flash frozen in liquid nitrogen.
Free biotinylated G␤␥ pulldown assay
Biotinylated G␤␥ pulldown assay was performed as described previously (27) , with minor modifications. Briefly, 50 ng purified PLC⑀-PH-RA2 or PH-RA1 was mixed with purified 15 nM bG␤␥ in the presence or absence of G␣ i1 -GDP for 2 h at 4°C in a rotator. 15 l 50% magnetic neutravidin bead (GE Healthcare) slurry was added to the mix and it was further incubated for 2 h. Pellet was washed thrice and subjected to gel electrophoresis and Western blot analysis.
Phospholipase C activity assay
The assay was performed as described previously (28), with minor modification. Briefly, lipids containing ϳ5000 cpm of [ 3 H-inositol]PIP 2 , 37.5 M PIP 2 , and 150 M phosphatidylethanolamine were mixed with 10 ng PLC⑀. Varying concentrations of G␤␥ (with or without preincubation with G ␣i1 -GDP (1:2 ratio)) were added to the PLC⑀ and the lipid mixture. The reaction was set at 30°C for 30 min and quenched using 5% BSA and 10% TCA. Released soluble [ 3 H]IP 3 was measured by liquid scintillation counting.
Statistical analysis
Data were analyzed using Prism 7 (GraphPad Software). Mean values and standard errors were calculated, and the statistical significance established using either Student's t test or
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one-way analysis of variance (ANOVA), as appropriate. All experiments were repeated at least three times.
